These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 18087196

  • 1. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S, Pinto AE, Laranjeira C, Quaresma M, Soares J.
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [Abstract] [Full Text] [Related]

  • 2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
    Michels JJ, Duigou F, Marnay J, Henry-Amar M, Delozier T, Denoux Y, Chasle J.
    Cancer; 2003 Mar 15; 97(6):1376-86. PubMed ID: 12627500
    [Abstract] [Full Text] [Related]

  • 4. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 15; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
    García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.
    Cancer Invest; 2006 Mar 15; 24(2):119-25. PubMed ID: 16537179
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2002 Mar 15; 22(1A):295-8. PubMed ID: 12017306
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer.
    Midulla C, De Iorio P, Nagar C, Pisani T, Cenci M, Valli C, Nofroni I, Vecchione A.
    Anticancer Res; 1999 Mar 15; 19(5B):4033-7. PubMed ID: 10628350
    [Abstract] [Full Text] [Related]

  • 8. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
    Liu JH, Huang H, Huang X, Zeng MS, Li W.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 07; 86(5):312-6. PubMed ID: 16677523
    [Abstract] [Full Text] [Related]

  • 9. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI, Glukhova EI, Zhukova LG, Ermilova VD, Bogatyrev VN, Baryshnikov AIu.
    Arkh Patol; 2003 Feb 07; 65(5):25-9. PubMed ID: 14664144
    [Abstract] [Full Text] [Related]

  • 10. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.
    Arch Med Res; 2007 Nov 07; 38(8):846-52. PubMed ID: 17923265
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS, Feil G, Bichler KH.
    Anticancer Res; 2000 Nov 07; 20(6D):5023-8. PubMed ID: 11326661
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
    Serra C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Merino AM, Baltasar A, Pérez-Vázquez MT, Medrano J.
    Int J Surg Investig; 2000 Nov 07; 2(3):183-92. PubMed ID: 12678518
    [Abstract] [Full Text] [Related]

  • 13. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
    O'Hanlon DM, Kiely M, MacConmara M, Al-Azzawi R, Connolly Y, Jeffers M, Keane FB.
    Eur J Surg Oncol; 2002 Mar 07; 28(2):103-7. PubMed ID: 11884043
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.
    J Urol; 2007 Feb 07; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA, El-Emshaty HM, Tabll A, Elmasry SA, Attallah AM, Gad Elhak NA.
    Hepatogastroenterology; 2004 Feb 07; 51(58):1001-6. PubMed ID: 15239234
    [Abstract] [Full Text] [Related]

  • 16. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
    Osterheld MC, Caron L, Meagher-Villemure K.
    Anticancer Res; 2008 Feb 07; 28(2A):751-6. PubMed ID: 18507016
    [Abstract] [Full Text] [Related]

  • 17. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S.
    Anticancer Res; 1994 Feb 07; 14(3B):1305-12. PubMed ID: 7915093
    [Abstract] [Full Text] [Related]

  • 18. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.
    Pinto AE, André S, Laranjeira C, Soares J.
    Pathology; 2005 Feb 07; 37(1):45-50. PubMed ID: 15875733
    [Abstract] [Full Text] [Related]

  • 19. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan 07; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 20. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S, Bui MM, Lu L.
    Ann Clin Lab Sci; 1998 Jan 07; 28(6):315-23. PubMed ID: 9846198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.